Приказ основних података о документу

dc.creatorStevanović, Magdalena
dc.date.accessioned2018-04-11T10:12:06Z
dc.date.available2019-03-31
dc.date.issued2017
dc.identifier.isbn978-0-323-46143-6
dc.identifier.urihttps://dais.sanu.ac.rs/123456789/2334
dc.description.abstractNanotechnology has great potential in the field of medicine and pharmacy because nano objects have comparable dimensions to biological entities. Polymer-based particles play an integral role as vehicles in the controlled delivery of different forms and types of active substances, such as anticancer drugs, antihypertensive and immunomodulatory agents, medical imaging contrast media, hormones, vitamins, and different macromolecules, such as nucleic acids (deoxyribonucleic acid, ribonucleic acid), proteins, antibodies, etc. The release of the active agent may be constant over a long period, it may be cyclic over a long period, or it may be triggered by the environment or other external events. The purpose behind controlling the drug delivery is to achieve more effective therapies while eliminating the potential for both under and overdosing. Other benefits of using controlled-delivery systems can include the maintenance of drug levels within a desired range, the need for fewer administrations, making optimal use of the drug in question, and increased patient compliance. This review article reports on obtaining polymeric micro- and nanoparticles with a special emphasis on obtaining polyester particles, the incorporation of different active substances within a polymer matrix, the degradation and release process of active substances from the polymeric particles, the physiochemical and biological properties of such obtained systems, as well as their application as drug-delivery systems.en
dc.format(2017) 355-378
dc.languageen
dc.publisherElsevier
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/45004/RS//
dc.rightsembargoedAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceNanostructures for Drug Deliveryen
dc.subjectnanotechnology
dc.subjectdrug delivery
dc.subjectpolymers
dc.subjectencapsulation
dc.subjectcarriers
dc.titleChapter 11 – Polymeric micro- and nanoparticles for controlled and targeted drug deliveryen
dc.typebookPart
dc.rights.licenseBY-NC-ND
dcterms.abstractСтевановић, Магдалена;
dc.citation.spage355
dc.citation.epage378
dc.identifier.doi10.1016/B978-0-323-46143-6.00011-7
dc.description.otherThis is the accepted manuscript of the book chapter: Wu, T.-J., Chiu, H.-Y., Yu, J., Cautela, M.P., Sarmento, B., das Neves, J., Catala, C., Pazos-Perez, N., Guerrini, L., Alvarez-Puebla, R.A., Vranješ-Đurić, S., Ignjatović, N.L., 2018. Nanotechnologies for early diagnosis, in situ disease monitoring, and prevention, in: Nanotechnologies in Preventive and Regenerative Medicine. Elsevier, pp. 1–92. [https://doi.org/10.1016/B978-0-323-48063-5.00001-0]
dc.type.versionacceptedVersion
dc.identifier.fulltexthttps://dais.sanu.ac.rs/bitstream/id/7109/10.1016-B978-0-323-46143-6.00011-7.pdf
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_dais_2334


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу